Excellent. International. Curious.
The physicians and scientists of the Department of Medicine 3 investigate the molecular and cellular mechanisms of rheumatic diseases and autoimmune diseases. Our aim is to enhance the knowledge of pathogenesis of the disease in order to develop innovative diagnostic and therapies that reduce patients' suffering, improve their quality of life and open up long-term treatment options.
In our translational research, we investigate the complex processes that characterise inflammation and autoimmune diseases. Therefore, we analyse how immune cells interact, how inflammatory processes are controlled and how tissues and organs - including metabolic processes - communicate with each other. These findings form the basis for the development of innovative diagnostic methods and targeted therapy concepts.
The close integration of basic research and clinical application enables us to integrate our findings quickly and effectively into patient care. Our overarching goal is to sustainably improve the quality of life of people with rheumatic and autoimmune diseases and to open up long-term healing possibilities. With this holistic approach to translational research, we are continuously working to remove limitations and create new hope for patients.
